You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 1, January 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis

A. Ayala, J. B. Knotts, W. Ertel, M. M. Perrin, M. H. Morrison and I. H. Chaudry
Department of Surgery, Michigan State University, East Lansing 48824.

We examined whether (1) there is an association between elevated circulating levels of transforming growth factor-beta (TGF-beta) and splenocyte dysfunction during sepsis, and (2) administration of monoclonal antibodies to interleukin 6 (an inducer of TGF-beta release) or TGF-beta could ablate these changes. Blood and splenocytes were obtained from C3H/HeN mice at 1, 4, or 24 hours following cecal ligation and puncture or sham operation. Only at 24 hours after cecal ligation and puncture was there an association between elevated blood TGF-beta value and depressed splenocyte interleukin 2 release. Administration of monoclonal antibodies against interleukin 6, but not against TGF-beta (intraperitoneally immediately following cecal ligation and puncture), significantly decreased the blood levels of TGF-beta at 24 hours following cecal ligation and puncture and improved splenocyte interleukin 2 release. Thus, the judicious use of monoclonal antibodies against interleukin 6 may block the subsequent elevation of TGF-beta, thereby attenuating host immunosuppression during sepsis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS
Cavaillon and Annane
Innate Immunity 2006;12:151-170.
ABSTRACT  

Infection by Gram-Negative Organisms via the Biliary Route Results in Greater Mortality than Portal Venous Infection
Jeyarajah et al.
CVI 2003;10:664-669.
ABSTRACT | FULL TEXT  

MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis
Song et al.
Am. J. Physiol. Cell Physiol. 2001;281:C662-C669.
ABSTRACT | FULL TEXT  

Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated
Chung et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2001;280:G812-G818.
ABSTRACT | FULL TEXT  

Review: Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review
Cavaillon et al.
Innate Immunity 2001;7:85-93.
ABSTRACT  

Hyporesponsiveness in leukocytes in sepsis: in vitro models reveal paradoxical effects of IL-10
Cavaillon et al.
Innate Immunity 1999;5:81-85.
ABSTRACT  

Is Fas Ligand or Endotoxin Responsible for Mucosal Lymphocyte Apoptosis in Sepsis?
Chung et al.
Arch Surg 1998;133:1213-1220.
ABSTRACT | FULL TEXT  

Inhibition of the Defense System Stimulating Interleukin-12 Interferon-gamma Pathway During Critical Illness
Ertel et al.
Blood 1997;89:1612-1620.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.